🟢 Outlook Therapeutics is trading 6% up today amid a broad biotech rebound

Outlook Therapeutics is trading at $0.52, up +5.88%, amid a broad biotech rebound; no company-specific catalyst for the gain has been identified.

• The XBI was up 2.77% by 1:28 p.m. ET.
• The company’s listed press releases show its October 9 announcement as the latest; no new announcement explaining the October 19 gain was identified.
• This follows reports of an FDA rejection of the company’s application over effectiveness and manufacturing concerns, a negative development that does not explain today’s rise.